Bronchoalveolar Lavage Fluid Microbiota is Associated with the Diagnosis and Prognosis Evaluation of Lung Cancer
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Supplementary Information: The online version contains supplementary material available at 10.1007/s43657-023-00135-9.
References
1.
Howlader N, Forjaz G, Mooradian M, Meza R, Kong C, Cronin K
. The Effect of Advances in Lung-Cancer Treatment on Population Mortality. N Engl J Med. 2020; 383(7):640-649.
PMC: 8577315.
DOI: 10.1056/NEJMoa1916623.
View
2.
Liu H, Tao L, Zhang J, Zhu Y, Zheng Y, Liu D
. Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer. 2017; 142(4):769-778.
DOI: 10.1002/ijc.31098.
View
3.
Mao J, Wang D, Long J, Yang X, Lin J, Song Y
. Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers. J Immunother Cancer. 2021; 9(12).
PMC: 8650503.
DOI: 10.1136/jitc-2021-003334.
View
4.
Marshall E, Filho F, Sin D, Lam S, Leung J, Lam W
. Distinct bronchial microbiome precedes clinical diagnosis of lung cancer. Mol Cancer. 2022; 21(1):68.
PMC: 8900294.
DOI: 10.1186/s12943-022-01544-6.
View
5.
Roberti M, Yonekura S, Duong C, Picard M, Ferrere G, Alou M
. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nat Med. 2020; 26(6):919-931.
DOI: 10.1038/s41591-020-0882-8.
View